Clinical Trials Logo

Any Solid Tumor clinical trials

View clinical trials related to Any Solid Tumor.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04521686 Active, not recruiting - Glioma Clinical Trials

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Start date: October 16, 2020
Phase: Phase 1
Study type: Interventional

This is an open-label, multicenter Phase 1 study to evaluate safety, tolerability and preliminary efficacy of oral LY3410738 in patients with isocitrate dehydrogenase 1 (IDH1) arginine 132 (R132)-mutant advanced solid tumors, including but not limited to cholangiocarcinoma, chondrosarcoma, and glioma or isocitrate dehydrogenase 2 (IDH2) arginine 140 (R140) or arginine 172 (R172) mutant cholangiocarcinoma.